Date: 2011-05-04
Type of information: Production agreement
Compound: newly discovered mammalian cell type capable of stimulating damaged tissues to regenerate
Company: Angel Biotechnology (UK) Pathfinder Cell Therapy (USA)
Therapeutic area:
Type agreement: manufacturing
production
Action mechanism:
Disease:
Details: The biopharmaceutical contract manufacturer Angel Biotechnology has announced an extension to the current contract with Pathfinder Cell Therapy. The extended contract reinforces Pathfinder Cell Therapy's commitment to the long term development of the Pathfinder Cell Platform and its use as a novel cell therapy in regenerative medicine.
Financial terms: Financial details of the deal were not disclosed.
Latest news:
